Evidence map›Paper›PMID 24606082›Full record

ArticleThe Journal of clinical endocrinology and metabolism2014

Reclassification of diabetes etiology in a family with multiple diabetes phenotypes.

Fotini K Kavvoura, Anne Raimondo, Gayathiry Thanabalasingham, Amy Barrett, Amanda L Webster, Debbie Shears, Nicholas P Mann, Sian Ellard, Anna L Gloyn, Katharine R Owen

Open access · hybridAbstract readCase Reports
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Fotini K KavvouraOxford Centre for Diabetes, Endocrinology, and Metabolism (F.K.K., A.R., G.T., A.B., A.L.W., A.L.G., K.R.O.), University of Oxford, Oxford OX3 7LE, United Kingdom; Oxford National Institute for Health Research Biomedical Centre (F.K.K., G.T., A.L.G., K.R.O.), Churchill Hospital, Oxford OX3 7LJ, United Kingdom; Department of Clinical Genetics (D.S.), Oxford University Hospitals National Health Service Trust, Oxford OX3 9DU, United Kingdom; Department of Pediatrics (N.P.M.), Royal Berkshire National Health Service Foundation Trust, Reading RG1 5AN, United Kingdom; and Institute of Biomedical and Clinical Science (S.E.), University of Exeter Medical School, Exeter EX4 4PY, United Kingdom.
Anne Raimondo
Gayathiry Thanabalasingham
Amy Barrett
Amanda L Webster
Debbie Shears
Nicholas P Mann
Sian Ellard
Anna L Gloyn
Katharine R Owen
University of Oxford · GBOxford Centre for Diabetes, Endocrinology and Metabolism · GBNational Health Service · GBRoyal Berkshire NHS Foundation Trust · GBUniversity of Exeter · GB

Funding

Wellcome Trust 095101Wellcome Trust 098395Wellcome Trust 95101/Z/10/Z
6 · The paper itself

Abstract

backgroundMaturity-onset diabetes of the young (MODY) is uncommon; however, accurate diagnosis facilitates personalized management and informs prognosis in probands and relatives.

objectiveThe objective of the study was to highlight that the appropriate use of genetic and nongenetic investigations leads to the correct classification of diabetes etiology. CASE DISCUSSION: A 30-year-old European female was diagnosed with insulin-treated gestational diabetes. She discontinued insulin after delivery; however, her fasting hyperglycemia persisted. β-Cell antibodies were negative and C-peptide was 0.79 nmol/L. Glucokinase (GCK)-MODY was suspected and confirmed by the identification of a GCK mutation (p.T206M).

methodsSystematic clinical and biochemical characterization and GCK mutational analysis were implemented to determine the diabetes etiology in five relatives. Functional characterization of GCK mutations was performed.

resultsIdentification of the p.T206M mutation in the proband's sister confirmed a diagnosis of GCK-MODY. Her daughter was diagnosed at 16 weeks with permanent neonatal diabetes (PNDM). Mutation analysis identified two GCK mutations that were inherited in trans-p. [(R43P);(T206M)], confirming a diagnosis of GCK-PNDM. Both mutations were shown to be kinetically inactivating. The proband's mother, other sister, and daughter all had a clinical diagnosis of type 1 diabetes, confirmed by undetectable C-peptide levels and β-cell antibody positivity. GCK mutations were not detected.

conclusionsTwo previously misclassified family members were shown to have GCK-MODY, whereas another was shown to have GCK-PNDM. A diagnosis of type 1 diabetes was confirmed in three relatives. This family exemplifies the importance of careful phenotyping and systematic evaluation of relatives after discovering monogenic diabetes in an individual.

Indexed as

AdultDiabetes, GestationalDiabetes Mellitus, Type 2FemaleHumansPedigreePregnancyPuerperal Disorders

Identifiers

PMID24606082
PMCPMC4186945
OpenAlexW2145944148

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.